Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation in Subjects With Chronic, Non-Malignant Pain

This study has been completed.
Information provided by:
Valeant Pharmaceuticals International, Inc. Identifier:
First received: August 19, 2010
Last updated: November 7, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)